Antimetabolites, Antineoplastic
Showing 1 - 25 of 172
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,
Not yet recruiting
- Carcinoma
- +8 more
- Hepatic arterial infusion chemotherapy
- +2 more
-
Guangzhou, Guangdong, ChinaLei Zhang
Sep 22, 2021
Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)
Recruiting
- Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Vincristine
- +9 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 13, 2022
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
Rectal Cancer Trial in Göteborg ([6R] 5,10-methylenetetrahydrofolate (arfolitixorin), Pemetrexed)
Completed
- Rectal Cancer
- [6R] 5,10-methylenetetrahydrofolate (arfolitixorin)
- Pemetrexed
-
Göteborg, SwedenSahlgrenska University Hospital
Sep 7, 2020
Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)
Recruiting
- Drug-Induced Acute Liver Injury
- Bicyclol tablets
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 2, 2023
Cirrhosis, Diabetes, Oncologic Disorders Trial in Spain (Esmolol Injection [Brevibloc])
Not yet recruiting
- Cirrhosis
- +2 more
- Esmolol Injection [Brevibloc]
-
Barcelona, Spain
- +5 more
Mar 15, 2023
CIPN and it's Impact on Quality of Life in Patients Receiving
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 24, 2023
Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)
Recruiting
- Advanced Pancreatic Cancer
- CT-707
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 17, 2022
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
RET-altered Solid Tumors Trial in Shanghai (APS03118)
Recruiting
- RET-altered Solid Tumors
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Dec 8, 2022
Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Stem Cell Transplantation
- busulfan, cyclophosphamide and melphalan, BuCyMel
- clofarabine, fludarabine and busulfan, CloFluBu
-
Brussels, Belgium
- +16 more
Jul 25, 2022
COVID Trial in Vienna (Azithromycin 500 milligram (mg) oral Tablet, Placebo)
Completed
- COVID
- Azithromycin 500 milligram (mg) oral Tablet
- Placebo
-
Vienna, AustriaAKH Vienna, Department for Internal Medicine I, Oncology
Apr 6, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun
Not yet recruiting
- RET-altered Non Small Cell Lung Cancer
- +3 more
-
Chang chun, Jilin, ChinaJinlin Province Cancer Hosipital
Dec 21, 2022
Breast Cancer After Ovarian Cancer During and/or After Therapy:
Recruiting
- BRCA-Associated Breast Carcinoma
- Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023
Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)
Not yet recruiting
- Endometrial Cancer
- +2 more
- Niraparib oral capsule
- (no location specified)
Oct 31, 2022
Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))
Recruiting
- Cancer
- Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Jul 18, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Ovarian Cancer Trial in Roma (Blood sample)
Recruiting
- Ovarian Cancer
- Blood sample
-
Roma, ItalyPoliclinico Universitario Agostino Gemelli
Oct 10, 2023
Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations
Recruiting
- Esophageal Squamous Cell Carcinoma
- +3 more
- Routine care as per site standard
-
Multiple Locations, GermanyMultiple sites, Gemany
Jun 3, 2022
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
Metastatic Cancers Trial in France (Blood sampling)
Completed
- Metastatic Cancers
- Blood sampling
-
Amiens, France
- +35 more
Sep 5, 2022
Stem Cell Transplantation Trial in Porto Alegre (Cycle ergometer, Strength Training - elastic band and shin guards, Cycle
Enrolling by invitation
- Stem Cell Transplantation
- Cycle ergometer
- +2 more
-
Porto Alegre, RS, BrazilSanta Casa de Misericórdia de Porto Alegre
Nov 10, 2023
Epithelial Ovarian Cancer Trial in Sweden (Tinzaparin Injectable Solution)
Recruiting
- Epithelial Ovarian Cancer
- Tinzaparin Injectable Solution
-
Eksjö, Sweden
- +5 more
Sep 28, 2022